کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
10970510 1103187 2007 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
موضوعات مرتبط
علوم زیستی و بیوفناوری ایمنی شناسی و میکروب شناسی ایمونولوژی
پیش نمایش صفحه اول مقاله
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza
چکیده انگلیسی
We used a propagation-defective, single-cycle, alphavirus replicon vector system to produce virus-like replicon particles (VRP) expressing the hemagglutinin (HA) and neuraminidase (NA) proteins from influenza A/Wyoming/03/2003 (H3N2). Efficient production methods were scaled to produce pilot lots of HA VRP and NA VRP and clinical lots of HA VRP. HA VRP-induced high-titered antibody responses in mice, rabbits and rhesus macaques, as measured by ELISA or hemagglutination inhibition (HI) assays, and robust cellular immune responses in mice and rhesus macaques, as measured by IFN-γ ELISPOT. NA VRP also induced cellular immune responses in mice. A toxicology study with HA VRP and NA VRP in rabbits showed no adverse effects in any parameter. These studies support clinical testing of alphavirus replicon vaccines for influenza.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 25, Issue 48, 23 November 2007, Pages 8180-8189
نویسندگان
, , , , , , , , , , , , , , , ,